Intravenous administration of adipose-derived mesenchymal stem cells can be applied for patients with hepatic cirrhosis at Medical Corporation Itanokai Kurume Central Hospital from October 2016.
Please click the link below for more details.
Inquiry by Phone
TEL: +81-92-435-6222
(Mon.-Fri. 9:00 a.m.-5:15 p.m., JST)
Inquiry by Email
We have started a stem cell banking service for future medical use. By using our service, adipose-derived mesenchymal stem cells can be cryopreserved/banked for autologous stem cell transplantation therapy.
Please click the link below if you are interested in our banking service.
Inquiry by Phone
TEL: +81-92-435-6222
(Mon.-Fri. 9:00 a.m.-5:15 p.m., JST)
Inquiry by Email
Intravenous administration of adipose-derived mesenchymal stem cells can be applied for patients with hepatic cirrhosis at Medical corporation Kaizuka hospital from October 2016.
Please click the link below for more details.
Patient recruitment was completed in September 2019.
Inquiry by Phone
TEL: +81-92-435-6222
(Mon.-Fri. 9:00 a.m.-5:15 p.m., JST)
Inquiry by Email
Cultivation service of adipose-derived mesenchymal stem cells used in the clinical trials at the Department of Advanced Medical Initiatives, Kyushu University for evaluating the safety and effectiveness of adipose-derived mesenchymal stem cells against hepatic cirrhosis has started since March 2016.
Patient recruitment was completed in March 2020.
The article about Japan Cell Culture, Inc. was published in Nikkei Biothech.
https://bio.nikkeibp.co.jp/article/news/20151001/187680/
（Member registration is required in order to read the article.）